
$7.0B+6% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $7.0B in 2025, compounding +3% a year since 2022 though the pace has cooled. The trailing twelve months are already running at $7.2B, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
$-843MFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The company lost $843M in 2025, more than the $312M it lost the year before. The losses are widening - check the Health chapter for how long the cash lasts.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
+5.8%revenue growth, FY 2025
Off the axis: 2013 earnings -376.1% · 2016 earnings +15834.4% · 2017 earnings +333.1% · 2020 earnings -1625.1% · 2023 earnings -320.6% - rebounds off a collapsed prior year.
→Revenue grew +6% in 2025 against a five-year average of +16%. 2013's swing into loss (-376%) and 2016's +15834% earnings rebound off a collapsed base and 2017's +333% earnings rebound off a collapsed base and 2020's swing into loss (-1625%) and 2023's swing into loss (-321%) sits off the axis.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
$-140MFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The business consumed $140M of cash in 2025 after investment. Growth is being funded from the balance sheet, not from operations.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow is negative, so no share of revenue is currently converting to spare cash. Every sales dollar is being reinvested or consumed.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→The biggest claim on each sales dollar is capital spending, at 9% of revenue (stock compensation 1%). That share has risen since 2022, so the cost of competing is climbing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Operating profit outgrew revenue in only 0 of the last 5 years. Costs are growing roughly in step with the business, so scale isn't yet paying for itself.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Operating margin compressed 25 points to -10% since 2022. The bottom line is still negative: costs below the operating line eat what is left. PENN doesn't tag a gross-profit line in its filings, so the chart starts at operating margin.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→ROE of -49% and ROCE of -5% sit close together, so the returns come from the business itself rather than from borrowing.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
0.3xP/S today
→At 0.3x sales, the market is paying 45% less than PENN's own 11-year median of 0.6x. Pessimism is priced in - the question is whether it is deserved. Today's multiple is the lowest in the charted history.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
4.2%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys 4.2% of annual free cash flow, less than its 11-year median of 8.9% - you are paying up for the same cash.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Debt of $2.8B sits against $887M of cash, or 1.5x shareholders' equity. Earnings don't currently cover the interest bill at all.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The company's own capital shrank from $3.2B in 2023 to $1.9B (-42%). Buybacks or losses are drawing the buffer down - the distinction matters.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Shareholders received $354M in buybacks in 2025. Stock compensation issued $61M of new shares in the same year, offsetting 17% of that.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The share count shrank 4.9% in 2025, averaging 6.3% a year over three years. Buybacks are concentrating your ownership: the same business, split fewer ways.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→PENN's return on capital is negative at -5.3% in 2025. The capital in the business is not yet earning anything back.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→PENN issued +35% more shares from 2011 to 2025, but revenue per share still rose +88%. The dilution bought more growth than it cost existing holders.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Insiders bought $2M and sold $115,891 on the open market, a net purchase of $2M. A further 47 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30